Case Details
- Citation: [2025] SGCA 3
- Court: Court of Appeal
- Civil Appeal No: Civil Appeal No 23 of 2024
- Originating Application No: Originating Application No 311 of 2023
- Date of decision (grounds of decision): 4 February 2025
- Date of hearing: 16 October 2024
- Judges: Sundaresh Menon CJ, Steven Chong JCA and Kannan Ramesh JAD
- Judgment author: Kannan Ramesh JAD (delivering the grounds of decision)
- Appellant: CH Biovest Pte Ltd
- Respondents: Envy Asset Management Pte Ltd (in liquidation); Bob Yap Cheng Ghee; Tay Puay Cheng; Toh Ai Ling
- Procedural posture: Appeal from the General Division of the High Court (liquidators’ clawback application)
- Lower court decision cited: Envy Asset Management Pte Ltd (in liquidation) and others v CH Biovest Pte Ltd [2024] SGHC 46
- Legal area: Insolvency law — avoidance of transactions (statutory clawback)
- Statutes referenced: Conveyancing and Law of Property Act (Cap 61, 1994 Rev Ed) (“CLPA”); Insolvency, Restructuring and Dissolution Act 2018 (Act 40 of 2018) (“IRDA”)
- Key statutory provisions (as described in the grounds): s 73B of the CLPA; s 224 of the IRDA
- Judgment length: 49 pages; 15,235 words
- Core factual theme: Ponzi scheme disguised as nickel trading; “profits” paid from other investors’ funds
Summary
In CH Biovest Pte Ltd v Envy Asset Management Pte Ltd (in liquidation) and others ([2025] SGCA 3), the Court of Appeal upheld the liquidators’ attempt to claw back “overwithdrawn” sums paid to an investor who had profited from a Ponzi scheme operated through Envy Asset Management Pte Ltd (“EAM”) and related entities. The court accepted that the Envy group’s purported nickel trading was fictitious and that the so-called profits paid to investors were funded by other investors rather than by any real trading activity.
The appeal turned on the statutory avoidance provisions relied upon by the liquidators. The liquidators sought recovery of the investor’s “profit” (not the full investment principal) under the avoidance regime for transactions made with an intent to defraud creditors (s 73B of the CLPA, applicable because the relevant payments were made before 30 July 2020) and under the undervalue transaction provisions in s 224 of the IRDA. The investor resisted, arguing, among other things, that the payments were not EAM’s assets because they were held on trust, that the wrong statutory provisions were chosen, and that it had provided consideration sufficient to defeat the statutory defences.
The Court of Appeal dismissed the appeal. It held that the statutory requirements for avoidance were satisfied and that the investor’s “consideration” arguments did not provide a defence. The court’s reasoning underscores that insolvency avoidance provisions are designed to protect the collective interests of creditors and to prevent unjust retention of value extracted from an insolvent or failing enterprise, even where the recipient frames the transaction as contractually entitled or trust-based.
What Were the Facts of This Case?
The underlying dispute arose from the collapse of the “Envy” group, which purported to operate a business of purchasing and reselling nickel. Investors were offered participation through Letters of Agreement (“LOAs”) with EAM. Under the LOAs, investors would provide an “Investment Amount” to be used for a three-month period to purchase LME Nickel Grade Metal at a discount from an Australian supplier, Poseidon Nickel Limited. Investors were promised repayment of their principal plus “Appreciation”, defined as the fair market value change of EAM’s liquid assets after deducting specified fees. The LOAs also included a minimum return guarantee of 85% of the Investment Amount if trades were not profitable.
Between June 2019 and February 2020, CH Biovest Pte Ltd (“CH Biovest”) entered into nine LOAs with EAM, investing a total of $5,480,246 and receiving $7,799,730. The difference—$2,319,484—was treated by the parties as the “profit” or “Overwithdrawn Sums”. Critically, it was agreed that there was no actual nickel trading carried out by EAM. Accordingly, any “profit” received by CH Biovest was fictitious and was paid out from funds invested by other investors.
Regulatory and criminal developments followed. In March 2020, the Monetary Authority of Singapore (“MAS”) placed EAM on its Investor Alert List, noting misrepresentations to investors about licensing applications. The scheme then evolved: operations were transferred to Envy Global Trading Pte Ltd (“EGT”), and the business model shifted to investors purchasing interests in purported receivables under forward contracts. This too proved unsustainable. In March 2021, the key person behind the Envy group, Mr Ng Yu Zhi (“NYZ”), was charged with cheating and fraudulent trading. Interim judicial managers were appointed in April 2021, and their report concluded that the purported nickel trading business was non-existent.
Following the judicial managers’ findings, winding up orders were made in August 2021 and liquidators were appointed. The liquidators commenced proceedings to recover the “Overwithdrawn Sums” from investors who had profited. The claim was deliberately restricted to the “profit” portion, not the entire sums paid to CH Biovest. CH Biovest resisted the clawback, asserting contractual entitlement and raising defences grounded in trust and consideration.
What Were the Key Legal Issues?
The Court of Appeal identified both preliminary and substantive issues. The first preliminary question was whether there was a threshold requirement to invoke the avoidance provisions for the “right type of transaction”. In other words, the court had to consider whether the statutory avoidance regime could be engaged given CH Biovest’s contention that the payments were never EAM’s assets because they were held on a Quistclose trust or an institutional constructive trust for investors.
The second preliminary issue was whether EAM was obliged to pay profits to the appellant. This mattered because CH Biovest framed its receipt as the performance of a contractual obligation under the LOAs, implying that the “profit” was not a gratuitous or avoidable transfer but rather the agreed return on investment.
On the substantive side, the court had to decide whether the payments could be avoided under s 73B of the CLPA and whether they could also be avoided under s 224 of the IRDA. For s 73B, the focus included whether the statutory defence in s 73B(3) applied—particularly whether CH Biovest provided consideration of adequate value. For s 224, the court examined whether the payments fell within the relevant limbs of s 224(3)(a), and whether EAM was unable to pay its debts at the time of the payments or became unable to do so as a result.
How Did the Court Analyse the Issues?
The Court of Appeal approached the case by first addressing the investor’s attempt to characterise the payments as outside the reach of insolvency avoidance. CH Biovest argued that the “Overwithdrawn Sums” were not EAM’s assets because they were held on trust. The court’s analysis reflects a careful distinction between (i) the investor’s contractual framing of entitlement and (ii) the insolvency law policy that avoidance provisions are meant to implement. Even if a recipient asserts a trust-based entitlement, the court must still determine whether the statutory conditions for avoidance are met and whether the transaction is properly characterised for insolvency purposes.
On the “threshold requirement” issue, the court rejected the notion that the avoidance provisions could not be invoked simply because the recipient alleged trust ownership. The court’s reasoning indicates that insolvency avoidance is not defeated by labels. Where the factual substratum shows that the scheme was fictitious and that payments were funded by other investors rather than by genuine trading profits, the court is prepared to treat the relevant payments as transactions capable of being avoided under the statutory regime. This approach aligns with the broader insolvency objective of preventing value extraction that undermines the equitable distribution of assets among creditors.
Turning to the question whether EAM was obliged to pay profits, the court accepted that the LOAs purported to create an obligation to pay “Investment Amount” and “Appreciation”. However, the court treated the existence of a contractual promise as insufficient to immunise the payments from avoidance where the promised “profit” was not the product of real performance. The court’s analysis implicitly recognises that in a Ponzi scheme context, contractual terms may be used to disguise distributions that are, in substance, withdrawals from a common pool funded by later investors. The court therefore focused on the statutory tests rather than on the contractual narrative.
For s 73B of the CLPA, the court examined the statutory elements for avoidance, including the intent to defraud creditors. It also considered the defence under s 73B(3), which requires that the recipient gave consideration of adequate value. The court held that CH Biovest did not provide consideration for the “Overwithdrawn Sums”. While CH Biovest had invested principal amounts under the LOAs, the “profit” portion was not supported by any corresponding value given to EAM at the time of the payments. The court’s reasoning emphasised that the statutory defence is not satisfied by general participation in the scheme; it requires adequate value in respect of the specific transfer sought to be avoided.
For s 224 of the IRDA, the court analysed whether the payments were undervalue transactions within the meaning of the provision. The court considered whether the payments fell within the second limb of s 224(3)(a) and, alternatively, whether they fell within the first limb. Although the detailed statutory mechanics are not fully reproduced in the extract provided, the court’s approach demonstrates a structured application of the provision’s limbs to the facts: the court assessed the nature of the consideration (if any) supporting the payments and the financial condition of EAM. The court also addressed whether EAM was unable to pay its debts at the time of the payments or became unable to do so as a result. In a Ponzi scheme collapse, the court’s reasoning reflects that the enterprise’s inability to sustain promised returns is central to the undervalue analysis.
Finally, the court’s treatment of the unjust enrichment claim (raised below and resisted on the basis of no total failure of consideration) is consistent with its overall conclusion that statutory avoidance provides the appropriate route for recovery in this insolvency context. While unjust enrichment principles can be relevant in some clawback scenarios, the Court of Appeal’s decision confirms that where Parliament has provided specific avoidance mechanisms, those mechanisms will typically govern the recovery analysis.
What Was the Outcome?
The Court of Appeal dismissed CH Biovest’s appeal. The effect of the dismissal was that the liquidators’ orders requiring CH Biovest to repay the “Overwithdrawn Sums” were upheld. Practically, CH Biovest was not permitted to retain the fictitious profits it had received, even though it had received those sums under LOAs that purported to entitle it to returns.
The outcome reinforces that, in insolvency clawback litigation arising from fraudulent schemes, courts will apply avoidance provisions robustly and will not allow contractual or trust-based characterisations to defeat statutory recovery where the statutory requirements are met.
Why Does This Case Matter?
This decision is significant for insolvency practitioners and law students because it illustrates how Singapore courts approach avoidance claims in the distinctive factual setting of Ponzi schemes. The case confirms that insolvency avoidance provisions are capable of reaching distributions framed as contractual “profits” where the underlying performance is fictitious and the payments are funded by other investors.
From a doctrinal perspective, the decision clarifies the limits of the “consideration” defence. The Court of Appeal’s emphasis that consideration must be provided for the specific transfer sought to be avoided (and must be of adequate value) is a useful analytical tool for future cases. Recipients cannot rely on the fact that they participated in the scheme or provided principal investment amounts to argue that they gave consideration for later withdrawals characterised as profits.
For practitioners, the case also highlights the importance of statutory choice and timing. The liquidators relied on s 73B of the CLPA for payments made before the IRDA’s effective date and on s 224 of the IRDA for the undervalue analysis. The Court of Appeal’s willingness to engage with the statutory framework demonstrates that courts will treat the avoidance regime as a coherent system, applying the correct provisions based on the temporal facts.
Legislation Referenced
- Conveyancing and Law of Property Act (Cap 61, 1994 Rev Ed) — s 73B (including s 73B(3))
- Insolvency, Restructuring and Dissolution Act 2018 (Act 40 of 2018) — s 224 (including s 224(3)(a))
Cases Cited
- Envy Asset Management Pte Ltd (in liquidation) and others v CH Biovest Pte Ltd [2024] SGHC 46
Source Documents
This article analyses [2025] SGCA 3 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.